Skip to content

Electrogastrography (EGC) in Premature Infants With Feeding Intolerance

Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00008736
Enrollment
Unknown
Registered
2001-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant, Newborn, Diseases

Keywords

Feeding intolerance, Infant, premature

Brief summary

Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.

Interventions

DRUGmetoclopramide

Sponsors

Children's Hospital of Philadelphia
CollaboratorOTHER
National Center for Research Resources (NCRR)
Lead SponsorNIH

Study design

Allocation
NON_RANDOMIZED
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
1 Minutes to 1 Months
Healthy volunteers
Yes

Inclusion criteria

Inclusion: Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026